Hantz Financial Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-421
Closed -$43K 2498
2025
Q4
$43K Buy
421
+211
+100% +$16.9K ﹤0.01% 1498
2025
Q3
$11K Buy
210
+6
+3% +$300 ﹤0.01% 1792
2025
Q2
$11K Hold
204
﹤0.01% 1473
2025
Q1
$9K Hold
204
﹤0.01% 990
2024
Q4
$11K Hold
204
﹤0.01% 802
2024
Q3
$14K Hold
204
﹤0.01% 758
2024
Q2
$9K Sell
204
-222
-52% -$12.2K ﹤0.01% 804
2024
Q1
$29K Hold
426
﹤0.01% 709
2023
Q4
$32K Hold
426
﹤0.01% 687
2023
Q3
$29K Sell
426
-11
-3% -$933 ﹤0.01% 685
2023
Q2
$41K Sell
437
-299
-41% -$23.3K ﹤0.01% 640
2023
Q1
$50K Hold
736
﹤0.01% 624
2022
Q4
$36K Buy
736
+122
+20% +$4.99K ﹤0.01% 635
2022
Q3
$20K Buy
614
+11
+2% +$454 ﹤0.01% 661
2022
Q2
$24K Hold
603
﹤0.01% 650
2022
Q1
$42K Buy
+603
New +$44.1K ﹤0.01% 624
2021
Q3
Sell
-5
Closed -$1K 824
2021
Q2
$1K Buy
+5
New +$597 ﹤0.01% 780

Other funds holding EXAS

Hantz Financial Services's EXAS Position: Q1 2026 in Review

Hantz Financial Services sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 421 shares — an estimated $43K sold.

Hantz Financial Services first reported a position in EXAS in Q2 2021 and held it in 17 quarters. The position peaked at $50K in Q1 2023. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Hantz Financial Services reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Hantz Financial Services sold 421 Exact Sciences shares in Q1 2026, an estimated $43K.
  • Hantz Financial Services first reported a position in Exact Sciences in Q2 2021 and held it in 17 quarters.
  • Hantz Financial Services's Exact Sciences position peaked at $50K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.